Houston, Mo.-based Texas County Memorial Hospital will close its Hutcheson Pharmacy on Aug. 21 after evaluating its retail pharmacy operations, according to a July 31 Ozark Radio News report. Hospital leaders cited recent manufacturing restrictions affecting retail pharmacy operations, ongoing…

Houston-based Memorial Hermann Health System has opened its fifth retail pharmacy, with four more planned across the system within the next year, Binita Patel, PharmD, vice president of pharmacy services, told Becker’s. The latest addition is a second location at…

The 340B Drug Pricing Program has faced mounting legal pressure throughout 2026, including Eli Lilly’s enforcement of a claims-data requirement that has left roughly 1,000 noncompliant covered entities exposed to suspended 340B pricing, and CVS’s motions to dismiss lawsuits from…

An FDA advisory committee voted 9-3 against Capricor Therapeutics’ cell therapy deramiocel for Duchenne muscular dystrophy-associated cardiomyopathy after concluding the available evidence did not demonstrate the therapy’s effectiveness. The vote followed FDA briefing documents released ahead of the meeting that…

The National Association of Boards of Pharmacy is developing a national adverse event reporting clearinghouse for compounded medications that will collect reports of patient harm and share them among state boards of pharmacy and the FDA. The organization said the…

Louisiana enacted legislation June 12 establishing new commercial reimbursement requirements for pharmacy benefit managers. The law creates a commercial market reimbursement floor and includes provisions intended to prevent PBMs from shifting costs to patients. Act 913, signed into law June…

CMS will discontinue the Part D premium stabilization program at the end of this year, returning the standalone prescription drug plan market to what the agency called “traditional market conditions.” CMS said July 28 its analysis of 2027 bids indicated…

Pharmacies in the Pittsburgh area are reporting shortages of estradiol patches used to treat menopause, perimenopause and gender dysphoria, according to a July 29 Pittsburgh Post-Gazette report. Pharmacists told the newspaper the supply constraints have lasted for months, with some…

Federal policy changes could reshape pharmacy reimbursement, drug pricing and hospital operations in 2027, according to a new Vizient outlook. The report, published July 27, highlights four pharmacy developments health systems should monitor as they plan for the year ahead.…

The FDA has published 17 revised draft product-specific guidances for peptide products, updating its recommendations for the development and assessment of certain generic peptide drugs. The revised draft guidances address the following peptide products, according to a July 28 agency…